Loading quotes...
Forecast
The analysts' average price target is €15.42 (+28.61%). The median is €15.42 (+28.61%).
| Buy |
5 |
| Hold |
6 |
| Sell |
0 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Takeover battle over InMode — Steel Partners offers $16.75 per share and demands removal of the CEO
Steel Partners Holdings has submitted a takeover bid of $16.75 per share, topping the $16.20 offer led by CEO Moshe Mizrahy; the bid represents roughly a 20% premium and allows shareholders to reinvest up to 40% of their holdings into the new company. Steel Partners urged the board to appoint an independent special committee and an independent investment bank and called for Mizrahy’s removal amid concerns about the conduct of the strategic review process, saying the CEO’s bid appears to undervalue the company. With a deadline set for July 13, the market sees the move as a significant step toward a premium exit, pushing InMode’s stock to the top of its 52-week range. » More on de.investing.com
InMode receives takeover offer from Steel Partners at $16.75
Steel Partners has made an all-cash takeover offer for InMode of $16.75 per share, representing roughly a 20% premium to the unaffected price and topping a competing bid from CEO Moshe Mizrahy. InMode shares rose in premarket trading; Steel is calling for the formation of an independent special committee and the engagement of an independent investment bank for negotiations. Steel also demands the removal of CEO Mizrahy and accuses him of suspicious stock purchases and possible insider trading; existing shareholders could reinvest up to 40% of their stake into the InMode led by Steel. The deadline to respond is July 13. » More on de.investing.com
InMode schedules annual general meeting for July 30 in Israel
InMode announced its annual general meeting for July 30, 2026 at 17:00 Israel time to be held at its business premises in Yokneam. Shareholders, according to an SEC filing, received a proxy statement dated June 18, 2026; the filing was signed by CEO Moshe Mizrahy. No further details on the agenda were disclosed. » More on de.investing.com
InMode announces share buyback of up to 10% of outstanding shares
InMode has announced a board-approved buyback program to acquire up to approximately 10% of its outstanding shares (about 6.38 million common shares). The repurchases will be funded from available cash and may be executed on the open market or by other permitted means, depending on market conditions. The company emphasizes strong cash flow despite a challenging macroeconomic environment and notes it has already repurchased roughly $127.4 million of shares in 2025; the program may be amended, suspended, or terminated at the company’s discretion. » More on de.investing.com
InMode announces buyback program for up to 6.38 million shares
InMode’s board approved a share buyback program for up to about 10% of outstanding shares (approximately 6.38 million common shares), to be funded from available cash. The company repurchased roughly $127.4 million of shares in 2025 and reports a strong balance sheet with a current ratio of 9.88. Repurchases may be made in the open market or by other permitted means depending on market conditions and can be adjusted, suspended or terminated at any time. The announcement comes despite a challenging macroeconomic environment; the stock trades at a P/E of 9.01 and has a market capitalization of $808 million. » More on de.investing.com
Financials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 81.34m | 2.46% |
| Gross profit | 63.38m | 2.87% |
| Net profit | 16.65m | 10.61% |
| EBITDA | 15.66m | 28.69% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €692.71m |
Number of shares | 57.54m |
52-week high/low | €15.12 - €11.54 |
| Dividends | No |
Beta | 1.99 |
P/E ratio | 10.79 |
PEG ratio | -0.25 |
P/B ratio | 1.17 |
P/S ratio | 2.04 |
Company profile
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
| Name | InMode |
| CEO | Moshe Mizrahy |
| Headquarters | Yokne'am,
ta Israel |
| Website | |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| IPO | 08/08/2019 |
| Employees | 660 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | INMD |
Frankfurt | 154.F |
Düsseldorf | 154.DU |
München | 154.MU |